PL2946782T3 - Preparaty farmaceutyczne zawierające siarczan chondroityny i pochodne kwasu hialuronowego - Google Patents

Preparaty farmaceutyczne zawierające siarczan chondroityny i pochodne kwasu hialuronowego

Info

Publication number
PL2946782T3
PL2946782T3 PL15171519T PL15171519T PL2946782T3 PL 2946782 T3 PL2946782 T3 PL 2946782T3 PL 15171519 T PL15171519 T PL 15171519T PL 15171519 T PL15171519 T PL 15171519T PL 2946782 T3 PL2946782 T3 PL 2946782T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
acid derivatives
pharmaceutical formulations
chondroitin sulfate
chondroitin
Prior art date
Application number
PL15171519T
Other languages
English (en)
Inventor
Monica Campisi
Giancarlo CARPANESE
Vincenza Corsa
Anna Maria Zanellato
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of PL2946782T3 publication Critical patent/PL2946782T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15171519T 2012-03-30 2013-03-27 Preparaty farmaceutyczne zawierające siarczan chondroityny i pochodne kwasu hialuronowego PL2946782T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT000098A ITPD20120098A1 (it) 2012-03-30 2012-03-30 "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
EP15171519.0A EP2946782B1 (en) 2012-03-30 2013-03-27 Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
PCT/IB2013/052443 WO2013144867A1 (en) 2012-03-30 2013-03-27 Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
EP13722549.6A EP2830636A1 (en) 2012-03-30 2013-03-27 Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives

Publications (1)

Publication Number Publication Date
PL2946782T3 true PL2946782T3 (pl) 2019-04-30

Family

ID=46000143

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15171519T PL2946782T3 (pl) 2012-03-30 2013-03-27 Preparaty farmaceutyczne zawierające siarczan chondroityny i pochodne kwasu hialuronowego

Country Status (12)

Country Link
US (2) US9655918B2 (pl)
EP (3) EP2946782B1 (pl)
CN (1) CN104220078A (pl)
CA (1) CA2868078C (pl)
EA (2) EA201792023A3 (pl)
ES (2) ES2887581T3 (pl)
HR (1) HRP20190131T1 (pl)
IT (1) ITPD20120098A1 (pl)
PL (1) PL2946782T3 (pl)
SI (1) SI2946782T1 (pl)
TR (1) TR201901472T4 (pl)
WO (1) WO2013144867A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITMI20132116A1 (it) * 2013-12-18 2015-06-19 Apharm Srl Associazione di glicosamminoglicani e ciclodestrine
CN104940221A (zh) * 2015-05-13 2015-09-30 北京大清生物技术有限公司 一种用于膀胱和尿道上皮损伤修复的组合物
EP3111941A1 (en) 2015-06-30 2017-01-04 Süleyman Patir Compositions comprising chondroitin sulfate for prophylaxis or treatment of damaged articular cartilage
EP3400950B1 (de) * 2017-05-12 2019-11-13 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (20 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
US11766421B2 (en) 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
AU2019417161B2 (en) 2018-12-27 2023-06-15 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
US11732060B2 (en) 2019-01-30 2023-08-22 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
IT201900024208A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Miscele iniettabili di acido ialuronico per uso in dermoestetica
TR201922907A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
CN111333879B (zh) * 2020-04-16 2022-08-16 山东众山生物科技有限公司 一种交联透明质酸的硫酸软骨素类化合物及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212892B (it) 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
DE3482812D1 (de) 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
IT1291291B1 (it) * 1997-04-30 1999-01-07 Chemedica Sa Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
DE10053053A1 (de) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
GB0130603D0 (en) * 2001-12-20 2002-02-06 Renaissance Healthcare Europ L Improvements in or relating to ophthalmic solutions
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
ES2374157T3 (es) * 2002-10-16 2012-02-14 Arthrodynamic Technologies, Animal Health Division, Inc. Tratamiento para la sinovitis traumática y el cartílago articular dañado.
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
ITMI20061030A1 (it) * 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
ITPD20060219A1 (it) * 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
IT1393945B1 (it) * 2009-04-21 2012-05-17 Fidia Farmaceutici Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"

Also Published As

Publication number Publication date
CA2868078C (en) 2020-04-14
ITPD20120098A1 (it) 2013-10-01
ES2887581T3 (es) 2021-12-23
EP2946782A3 (en) 2016-02-24
EA029237B1 (ru) 2018-02-28
EP2830636A1 (en) 2015-02-04
CA2868078A1 (en) 2013-10-03
HRP20190131T1 (hr) 2019-03-22
US9655918B2 (en) 2017-05-23
EA201792023A3 (ru) 2018-04-30
ES2709799T3 (es) 2019-04-17
SI2946782T1 (sl) 2019-03-29
CN104220078A (zh) 2014-12-17
TR201901472T4 (tr) 2019-02-21
WO2013144867A1 (en) 2013-10-03
EP2946782B1 (en) 2018-11-07
EP3449927B1 (en) 2021-06-23
US20170216344A1 (en) 2017-08-03
EP2946782A2 (en) 2015-11-25
EP3449927A1 (en) 2019-03-06
US20150072954A1 (en) 2015-03-12
EA201401074A1 (ru) 2015-01-30
US10821131B2 (en) 2020-11-03
EA201792023A2 (ru) 2018-01-31

Similar Documents

Publication Publication Date Title
HRP20190131T1 (hr) Farmaceutske formulacije koje sadrže hondroitin-sulfat i derivate hijaluronske kiseline
IL233756A (en) History of hydroxamic acid and their pharmaceutical preparations
HK1205690A1 (en) Pharmaceutical composition and administration thereof
IL252566A0 (en) Pharmacy preparations and methods
IL236024A (en) The history of benzimidazole-proline and its pharmaceutical preparations
EP2842945A4 (en) SULFONAMIDE DERIVATIVE AND MEDICAL USE THEREOF
IL250370A0 (en) Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals
HK1203947A1 (en) Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions (halofuginol)
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
IL249825A0 (en) Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations
HK1205698A1 (en) Chondroitin for use in medicine
HK1210941A1 (en) Modified hyaluronic acid derivatives and use thereof
HK1187335A1 (en) Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3--
EP2874987A4 (en) ALPHA AND GAMMA TRUXILLINIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
GB201208315D0 (en) Pharmaceutical methods and compositions
HK1203955A1 (zh) 反式- -癸烯酸衍生物及含有其的藥物
HUE045699T2 (hu) Genotípus- és fenotípus-alapú gyógyászati készítmények
HK1209339A1 (en) Pharmaceutical formulations
GB201211406D0 (en) Pharmaceutical formulations
GB201211403D0 (en) Pharmaceutical formulations